COVID-19 Vaccine: Bharat Biotech To Carry Out Clinical Trials In the United States To Support Marketing Application For Covaxin
Bharat Biotech informed that it will be carrying out clinical trials in the United States to support the marketing application for Covaxin. Earlier Covaxin was denied approval by FDA in America and is now looking to bring Covaxin In the US with new recommedations.
Bharat Biotech said that it will be carrying out clinical trials in the United States to support the marketing application for Covaxin.
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)